Intended for healthcare professionals


A rash refractory to treatment

BMJ 2020; 369 doi: (Published 30 April 2020) Cite this as: BMJ 2020;369:m1703
  1. Mark Eisner, LAS dermatology,
  2. Elizabeth West, consultant dermatologist
  1. Department of Dermatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
  1. Correspondence to M Eisner mark.eisner{at}

This (fig 1) is carcinoma erysipeloides (cutaneous metastatic breast cancer), of a woman in her 70s. She presented with an eight month history of …

View Full Text

Log in

Log in through your institution


* For online subscription